Video Series: Current Topics in the Treatment of Advanced PCa

Targeted Agents

Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.

Latest Prostate Cancer Features

MRI/US Fusion Improves Prostate Cancer Detection

MRI/US Fusion Improves Prostate Cancer Detection

The approach can help identify suitable candidates for active surveillance, but false positives and cost effectiveness are concerns.

Latest Prostate Cancer News

CTCs May Aid Prostate Cancer Risk Stratification

CTCs May Aid Prostate Cancer Risk Stratification

Analysis of circulating tumor cells may help identify patients at higher risk of biochemical recurrence after treatment.

PCa Cryoablation Achieves Acceptable Outcomes

PCa Cryoablation Achieves Acceptable Outcomes

In a study, the 5-year estimated biochemical failure-free survival rate, based on the Phoenix definition, was 84%.

Infections After Prostate Biopsy Continue to Rise

Infections After Prostate Biopsy Continue to Rise

Patients are at higher risk with the transrectal rather than transperineal approach.

Mindfulness-Based Cognitive Therapy Ineffective in Advanced PCa

Mindfulness-Based Cognitive Therapy Ineffective in Advanced PCa

The researchers observed no significant changes in intervention outcomes or in engagement with mindfulness for men with PC.

Survival Benefit Linked With Adjuvant RT+ADT in Lymph Node + PCa

Survival Benefit Linked With Adjuvant RT+ADT in Lymph Node + PCa

Radiation treatment plus androgen deprivation therapy (ADT) after radical prostatectomy was associated with an overall survival benefit.

ADT Not Linked to Dementia in Nonmetastatic Prostate Cancer

ADT Not Linked to Dementia in Nonmetastatic Prostate Cancer

No increased risk of dementia for androgen deprivation therapy use versus nonuse.

Prostate Cancer Incidence Lower in HIV-Infected Men

Prostate Cancer Incidence Lower in HIV-Infected Men

HIV-infected men and women had lower incidences of colorectal and lung cancer compared with the general population.

Cancer Patients Benefit From Exercise During, After Treatment

Cancer Patients Benefit From Exercise During, After Treatment

At the end of 3 months, the exercise and diet group was walking 3 to 4 times more quickly in a timed walk test of about a quarter-mile than the usual care group.

Study: 5-ARIs Do Not Increase PCa Death Risk

Study: 5-ARIs Do Not Increase PCa Death Risk

New findings confirm previous reports.

Guidelines Developed for Prostate MRI After Negative Biopsy

Guidelines Developed for Prostate MRI After Negative Biopsy

High-quality prostate MRI should be strongly considered for any patient with a prior negative biopsy who is under evaluation for a repeat biopsy.

Adjuvant RT+ADT Linked With Survival Advantage in Lymph Node Positive PCa

Adjuvant RT+ADT Linked With Survival Advantage in Lymph Node Positive PCa

Radiation treatment plus androgen deprivation therapy (ADT) after radical prostatectomy was associated with an overall survival benefit.

Second Opinions Rarely Alter PCa Treatment Decisions

Second Opinions Rarely Alter PCa Treatment Decisions

Obtaining second opinions was not associated with changes in treatment choice or with improvements in how patients viewed their quality of cancer care.

Fewer Prostate Biopsies After USPSTF Limited PSA Screening

Fewer Prostate Biopsies After USPSTF Limited PSA Screening

Following the 2012 USPSTF recommendation against PSA screening in populations, rates of radical prostatectomy and biopsy have become significantly less common.

Biases Suspected in Prostate Cancer Risk Estimates

Biases Suspected in Prostate Cancer Risk Estimates

Incident prostate cancer cohorts were defined by examining men who were regularly screened from the placebo arms of two large prostate cancer prevention trials.

PSA Error in the SEER Database Lower Than Suspected

PSA Error in the SEER Database Lower Than Suspected

The error rate due to the implied decimal point used for prostate-specific antigen (PSA) results is substantially lower than previously noted.

Sign up for free e-Newsletters